Abstract PS4-08-26: Weekly carboplatin and paclitaxel with trastuzumab and pertuzumab (HER2+) or bevacizumab (HER2-) in the neoadjuvant treatment of breast cancer: a phase II trial
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129927346
Cites:
Cited by:
Related to:
